151 related articles for article (PubMed ID: 21926045)
1. Pulmonary cryptococcoma in a patient with Sézary syndrome treated with alemtuzumab.
Hotz C; Ingen-Housz-Oro S; Tran Van Nhieu J; Charlier C; Foulet F; Rahmouni A; Zegai B; Duong TA; Wolkenstein P; Bagot M; Chosidow O
Eur J Dermatol; 2011; 21(6):1018-20. PubMed ID: 21926045
[No Abstract] [Full Text] [Related]
2. Can the level of CD52 expression on Sézary cells be used to predict the response of Sézary syndrome to alemtuzumab?
Fernandes IC; Gonçalves M; dos Anjos Teixeira M; Gonçalves C; Coutinho J; Selores M; Alves R; Lima M
J Am Acad Dermatol; 2012 Nov; 67(5):1083-5. PubMed ID: 23062898
[No Abstract] [Full Text] [Related]
3. Cryptococcus neoformans fatal sepsis in a chronic lymphocytic leukemia patient treated with alemtuzumab: case report and review of the literature.
Bassetti M; Repetto E; Mikulska M; Miglino M; Clavio M; Gobbi M; Righi E; Viscoli C
J Chemother; 2009 Apr; 21(2):211-4. PubMed ID: 19423476
[TBL] [Abstract][Full Text] [Related]
4. Alemtuzumab in refractory Sézary syndrome.
Reifs CM; Salido-Vallejo R; Garnacho-Saucedo GM; Corte-Sánchez S; González-Menchen A; García-Nieto AV
An Bras Dermatol; 2016; 91(5):642-644. PubMed ID: 27828640
[TBL] [Abstract][Full Text] [Related]
5. Alemtuzumab in Sézary syndrome: efficient but not innocent.
Ure UB; Ar MC; Salihoglu A; Guner SI; Baran A; Oguz O; Ferhanoglu B
Eur J Dermatol; 2007; 17(6):525-9. PubMed ID: 17951134
[TBL] [Abstract][Full Text] [Related]
6. Treatment of Sézary Syndrome With Alemtuzumab: A Series of 5 Cases and a Review of the Literature.
del Alcázar-Viladomiu E; Tuneu-Valls A; López-Pestaña A; Vidal-Manceñido MJ
Actas Dermosifiliogr; 2015 Sep; 106(7):e33-9. PubMed ID: 25960287
[TBL] [Abstract][Full Text] [Related]
7. Visceral leishmaniasis after alemtuzumab in a patient with chronic lymphocytic leukaemia.
Pitini V; Cascio A; Arrigo C; Altavilla G
Br J Haematol; 2012 Jan; 156(1):1. PubMed ID: 21790529
[No Abstract] [Full Text] [Related]
8. Cutaneous hemophagocytosis after alemtuzumab injection in a patient with Sézary syndrome.
Jawed SI; Busam K; Wang X; Horwitz S; Querfeld C
JAMA Dermatol; 2014 Sep; 150(9):1021-3. PubMed ID: 25029560
[No Abstract] [Full Text] [Related]
9. Alemtuzumab treatment for Sézary syndrome: A single-center experience.
Novelli S; García-Muret P; Sierra J; Briones J
J Dermatolog Treat; 2016; 27(2):179-81. PubMed ID: 26329989
[TBL] [Abstract][Full Text] [Related]
10. Alemtuzumab-resistant Sézary syndrome responding to zanolimumab.
Alexandroff AB; Shpadaruk V; Bamford WM; Kennedy DB; Burd R; Dyer MJ
Br J Haematol; 2011 Aug; 154(3):419-21. PubMed ID: 21480857
[No Abstract] [Full Text] [Related]
11. Cutaneous cryptococcus infection due to C. albidus associated with Sézary syndrome.
Narayan S; Batta K; Colloby P; Tan CY
Br J Dermatol; 2000 Sep; 143(3):632-4. PubMed ID: 10971343
[TBL] [Abstract][Full Text] [Related]
12. Sezary syndrome presenting with leonine facies and treated with low-dose subcutaneous alemtuzumab.
Oliveira A; Lobo I; Alves R; Lima M; Selores M
Dermatol Online J; 2011 Nov; 17(11):6. PubMed ID: 22136862
[TBL] [Abstract][Full Text] [Related]
13. Fatal adenoviral and enteroviral infections and an Epstein-Barr virus positive large B-cell lymphoma after alemtuzumab treatment in a patient with refractory Sézary syndrome.
Roch N; Salameire D; Gressin R; Morand P; Epaulard O; Pavese P; Brion JP; Stahl JP
Scand J Infect Dis; 2008; 40(4):343-6. PubMed ID: 17934981
[TBL] [Abstract][Full Text] [Related]
14. Cutaneous cryptococcosis mimicking basal cell carcinoma in a patient with Sézary syndrome.
Töröcsik D; Gergely L; Veres I; Remenyik É; Bégány Á
Acta Derm Venereol; 2012 May; 92(3):286-7. PubMed ID: 22434510
[No Abstract] [Full Text] [Related]
15. A Sézary cryptogram. Disseminated cryptococcal infection.
Desar IM; Stevens WB; Verweij PE; van der Velden WJ
Neth J Med; 2011; 69(7):346, 349. PubMed ID: 21934182
[No Abstract] [Full Text] [Related]
16. Cryptococcoma of a transplanted kidney in a patient presenting with recurrent urinary tract infection: a case report.
Muranda AZ; Greeff L; Sathekge MM; Lengano T; Karusseit VOL
BMC Nephrol; 2018 Apr; 19(1):94. PubMed ID: 29688849
[TBL] [Abstract][Full Text] [Related]
17. Miliary pulmonary cryptococcosis in a patient with the acquired immunodeficiency syndrome.
Douketis JD; Kesten S
Thorax; 1993 Apr; 48(4):402-3. PubMed ID: 8511742
[TBL] [Abstract][Full Text] [Related]
18. Successful treatment of chemotherapy-refractory Sézary syndrome with alemtuzumab (Campath-1H).
Gautschi O; Blumenthal N; Streit M; Solenthaler M; Hunziker T; Zenhäusern R
Eur J Haematol; 2004 Jan; 72(1):61-3. PubMed ID: 14962265
[TBL] [Abstract][Full Text] [Related]
19. A ten-year-old boy with a pulmonary nodule secondary to Cryptococcus neoformans: case report and review of the literature.
Sweeney DA; Caserta MT; Korones DN; Casadevall A; Goldman DL
Pediatr Infect Dis J; 2003 Dec; 22(12):1089-93. PubMed ID: 14688572
[TBL] [Abstract][Full Text] [Related]
20. [A case report--pulmonary cryptococcosis associated with systemic lupus erythematosus and review of 44 cases in Japan].
Sato M; Saku N; Takeda A; Suzuki N; Saito T; Minato N; Saito K; Kano S
Ryumachi; 1993 Feb; 33(1):56-62. PubMed ID: 8493585
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
